Fundz

AngioInsight Appoints Scott Burger as Chief Executive Officer

PRIVATEDec 17, 2024

Position

Chief Executive Officer

Company

AngioInsight

Scott Burger
sburger@angioinsight.com
United StatesBiotechnologyHealth CareMedicalHealth Diagnostics

Description

AngioInsight, Inc. is pleased to announce the appointment of Scott Burger as its Chief Executive Officer (CEO). Scott brings over two decades of extensive leadership experience in the healthcare and medical technology sectors, positioning him perfectly to lead AngioInsight into its next phase of growth and innovation.

Quick answer

AngioInsight Appoints Scott Burger as Chief Executive Officer (December 17, 2024). AngioInsight is based in United States.

Who is the new Chief Executive Officer at AngioInsight?
AngioInsight named Scott Burger Chief Executive Officer, announced December 17, 2024.
What did AngioInsight announce on December 17, 2024?
AngioInsight, Inc. is pleased to announce the appointment of Scott Burger as its Chief Executive Officer (CEO). Scott brings over two decades of extensive leadership experience in the healthcare and medical technology sectors, positioning him perfectly to lead AngioInsight into its next phase of growth and innovation.
What does AngioInsight do?
AngioInsight, Inc. is a pioneering developer of an advanced AI solution aimed at transforming the way cardiovascular diseases are diagnosed and managed.
Where is AngioInsight based?
AngioInsight is based in United States.
Which similar companies made leadership changes around the same time?
NeoGenomics (January 10, 2025), Labcorp (November 19, 2024), AirSculpt Technologies (December 17, 2024) and Nicklas Medical Staffing (December 17, 2024) also announced leadership changes within 45 days of AngioInsight.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Health Diagnostics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at AngioInsight, and when

A new leader at AngioInsight brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day AngioInsight raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AngioInsight, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AngioInsight. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AngioInsight

Location

United States

About

AngioInsight, Inc. is a pioneering developer of an advanced AI solution aimed at transforming the way cardiovascular diseases are diagnosed and managed. The company's proprietary platform provides clinicians with real-time insights for both anatomical and functional assessment, as well as detection of microvascular disease often missed or misdiagnosed, especially in women. The goal is to enable more accurate and actionable patient care, aiming to reduce the cost of care through AI’s accuracy and efficiency. AngioInsight has not received FDA clearance.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AngioInsight changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Judy
Likely contact at this company
••••••••@••••••••

See Judy's verified email →

Scott
Likely contact at this company
••••••••@••••••••

See Scott's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for AngioInsight's next move

Learn about Strategic plan

AngioInsight changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.